September 29, 2009 - Positron Corp., a molecular imaging solutions company focused on nuclear cardiology, will attend the 14th Annual American Society of Nuclear Cardiology (ASNC) annual conference in Minneapolis, Minn. Oct. 1-4, to showcase their newly developed cardiac optimized PET scanner, the Attrius.

Positron will showcase its newly designed, cardiac optimized PET scanner, designed for the cardiovascular PET imaging in physician's offices. The Attrius reduces radiation exposure, said Joseph Oliverio, CTO of Positron. "The Attrius has a small footprint, robust standard cardiovascular software package, competitive scan times and an affordable cost of entry making the Attrius the right choice for enhancing the capabilities of a cardiovascular practices, while providing better care," he said.

For more information: www.positron.com


Related Content

News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
News | Molecular Imaging

Oct. 15, 2026 — GE HealthCare has announced that its MINItrace Magni cyclotron has achieved CE Mark and that its ...

Time October 16, 2026
arrow
News | Information Technology

October 6, 2026 – Clearsense has introduced a cloud-based medical image archive designed to reduce the cost of ...

Time October 07, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 5, 2026 — GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based CMO for PET ...

Time October 06, 2026
arrow
News | PET-MRI

Sept. 29, 2026 —Yale New Haven Hospital has installed a state-of-the-art positron emission tomography/magnetic resonance ...

Time October 05, 2026
arrow
News | Radiopharmaceuticals and Tracers

Aug. 30, 2026 — Bayer has announced the presentation of first detailed results from the Phase III REVEAL study, an ...

Time September 02, 2026
arrow
News | PET-MRI

June 10, 2026 — UTHealth Houston has launched a state-of-the-art PET/MRI imaging service, bringing together two advanced ...

Time June 12, 2026
arrow
News | Nuclear Imaging

June 1, 2026 — At the 2026 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, GE HealthCare will ...

Time June 02, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...

Time May 08, 2026
arrow
Subscribe Now